我要投票 华信HXZY在阿胶行业中的票数:69
· 外 推 电 报 ·
2025-02-02 12:28:01 星期日

【华信HXZY是哪个国家的品牌?】

华信HXZY是什么牌子?「华信HXZY」是 山东华信制药集团股份有限公司 旗下著名品牌。该品牌发源于山东,由创始人陆一峰在2002-03-29期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

山东华信制药集团创建于2002年3月,总部位于菏泽市高新技术产业园,拥有胶剂、大容量注射剂、片剂、颗粒剂、胶囊剂、口服溶液剂等10个剂型,均一次性顺利通过新版GMP认证。历经风雨十余载,华信集团完成了凤凰涅槃般地美丽蜕变,从一个名不见经传的小厂成长为集科研开发、药品制造、医药经贸于一体的现代化综合性制药集团。

山东华信制药集团自成立以来以“打造民族品牌”为己任,大力发展阿胶产业,加大华信阿胶系列产品的市场开发和拓展,对目标市场进行深耕细作,实施全员营销战略,以阿胶为品牌根基品种,与主要连锁经销商、零售商共同打造百城万家连锁终端市场,抓好终端市场的开发和以省级大区为单位的渠道网络建设,不断推出国食健字阿胶保健品以及阿胶食品,注重阿胶系列产品的规模化运作和规范化经营,实现阿胶全产业链运作,使华信集团向阿胶制品深加工、产业结构多元化、产品系列化、资本收益最大化的格局稳步发展。

华信集团新推出上呼吸道感染主打产品群——独家专利产品、国家三类新药:龙香平喘胶囊、伪麻那敏胶囊、美愈伪麻口服液等产品是公司近两年重点培育的新品种,这也是公司新的经济增长点,在全国的市场营销战略正全面推进,逐步构建以地级市为中心的覆盖各等级医院及社区门诊的销售网络和渠道。以新药龙香平喘胶囊、益中生血胶囊、紫丹活血胶囊、伪麻那敏胶囊、美愈伪麻口服溶液,饮片胶丁为主的临床终端产品正不断刷新销售记录,持续攀升市场占有率,实现终端市场的新突破。

华信制药集团将继续做好产品结构调整,企业转型升级,聚焦主推产品(阿胶、新药),实施大品种、大终端、大健康的发展战略,规范企业运作,建立完善现代企业制度,对接资本市场,建立健全药品全过程的质量控制体系,实行精细化管理,智能化制造,始终如一地追求药品的安全和显著的功能疗效,以实现华信的新腾飞。

英文翻译:Shandong Huaxin Pharmaceutical Group, founded in March 2002, is headquartered in Heze high tech Industrial Park. It has 10 dosage forms including gel, large volume injection, tablet, granule, capsule and oral solution, all of which have successfully passed the new GMP certification at one time. After more than ten years of ups and downs, Huaxin group has completed a beautiful transformation like Phoenix Nirvana, growing from an unknown small factory to a modern comprehensive pharmaceutical group integrating scientific research and development, pharmaceutical manufacturing and pharmaceutical trade. Since its establishment, Shandong Huaxin Pharmaceutical Group has taken "building a national brand" as its own duty, vigorously developed the gelatin industry, increased the market development and expansion of the gelatin series products of Huaxin, deeply cultivated the target market, implemented the marketing strategy of the whole staff, took the gelatin as the basic brand variety, and worked with the main chain dealers and retailers to build a chain terminal market of one hundred cities and ten thousand stores, to make the best of it The development of the end market and the construction of the channel network with the provincial region as the unit, continuously launched the national food Jianzi donkey hide gelatin health products and donkey hide gelatin food, paid attention to the large-scale operation and standardized operation of the donkey hide gelatin series products, realized the operation of the whole industrial chain of donkey hide gelatin, and made Huaxin group steadily distribute to the pattern of the deep processing of donkey hide gelatin products, the diversification of industrial structure, the serialization of products and the maximization of capital gains Exhibition. Huaxin group has newly launched the main product group of upper respiratory tract infection - exclusive patent products, three kinds of national new drugs: Longxiang Pingchuan capsule, pseudoephedrine capsule, Meiyu pseudoephedrine oral liquid and other products, which are the company's key cultivation new varieties in the past two years, which are also the company's new economic growth point. The national marketing strategy is being promoted in an all-round way, and gradually building a coverage centered on prefecture level cities Sales network and channels of all levels of hospitals and community clinics. The clinical terminal products, mainly composed of new drugs Longxiang Pingchuan capsule, Yizhong Shengxue capsule, Zidan Huoxue Capsule, pseudo Ma Namin capsule, Meiyu pseudo Ma oral solution, and decoction pieces Jiaoding, are constantly refreshing their sales records, continuously increasing their market share, and achieving new breakthroughs in the terminal market. Huaxin Pharmaceutical Group will continue to do a good job in product structure adjustment, enterprise transformation and upgrading, focus on the main products (donkey hide gelatin, new drugs), implement the development strategy of large varieties, large terminals and large health, standardize enterprise operation, establish and improve modern enterprise system, connect capital market, establish and improve the quality control system of the whole process of drugs, implement fine management and intelligent manufacturing, and always Such as the pursuit of drug safety and significant functional efficacy, in order to achieve the new take-off of Huaxin.

本文链接: https://www.waitui.com/brand/9d5f26ed9.html 联系电话:05305923283

千城特选小程序码

7×24h 快讯

加拿大总理特鲁多表示,将对价值1550亿加元的美国商品征收25%的关税

加拿大总理特鲁多表示,加拿大将对价值1550亿加元的美国商品征收25%的关税。从周二起立即对价值300亿加元的商品征收关税。(财联社)

28分钟前

英特尔:为DeepSeek大模型提供优化工具,降低部署门槛

近日,DeepSeek推出了一款名为Janus Pro的先进AIGC(人工智能生成内容)模型,该模型以其卓越的性能和高精度引起了行业的广泛关注。2月2日,英特尔方面表示,英特尔® Gaudi 2D AI加速器针对Janus Pro进行了优化,为AI开发者提供了以更低的成本和更高的效率部署复杂任务的可能性,满足了行业对于推理计算能力的需求。(新浪财经)

28分钟前

商务部新闻发言人就美方宣布对中国输美产品加征10%关税发表谈话

美国东部时间2月1日晚8时许,美白宫发布事实清单,宣布以芬太尼等问题为由对中国输美产品加征10%关税。中方对此强烈不满,坚决反对。美方单边加征关税的做法严重违反世贸组织规则,不仅无益于解决自身问题,也对中美正常经贸合作造成破坏。对于美方的错误做法,中方将向世贸组织提起诉讼,并将采取相应反制措施坚定维护自身权益。中方希望美方客观、理性看待和处理自身芬太尼等问题,而不是动辄以关税手段威胁他国。中方敦促美方纠正错误做法,与中方相向而行,在平等互利、相互尊重基础上,直面问题,坦诚对话,加强合作,管控分歧。(商务部新闻办公室)

28分钟前

鸿蒙智行1月全系交付新车34987辆

据鸿蒙智行官方,2025年2月1日,鸿蒙智行2025年首月销量新鲜出炉,凭借着在在中高端市场的持续发力,1月全系交付新车34987辆,实现了新年首月销量的开门红。

28分钟前

保险业2024年原保险保费收入约5.7万亿元

国家金融监督管理总局发布的数据显示,2024年,中国保险业原保险保费收入约5.7万亿元,其中财产险1.43万亿元、人身险4.26万亿元。在赔付方面,2024年中国保险业原保险赔付支出2.3万亿元,其中财产险9810亿元、人身险1.32万亿元。截至2024年末,中国保险业总资产35.9万亿元,净资产3.32万亿元。(财联社)

28分钟前

本页详细列出关于东健阿胶的品牌信息,含品牌所属公司介绍,东健阿胶所处行业的品牌地位及优势。
咨询